{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T20:28:42Z","timestamp":1748032122495},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1038\/sj.bdj.4812742","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T16:54:45Z","timestamp":1128704085000},"page":"433-435","source":"Crossref","is-referenced-by-count":5,"title":["Low grade multiple myeloma that presented as a labial swelling \u2014 A case report"],"prefix":"10.1038","volume":"199","author":[{"given":"S","family":"Ariyaratnam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Duxbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,8]]},"reference":[{"key":"BF4812742_CR1","first-page":"347","volume-title":"Epidemiology of multiple myeloma","author":"DA Reidel","year":"1991","unstructured":"Reidel DA, Potten LM, Blattner WA . Epidemiology of multiple myeloma. In Wiernik P H, Canellos G P, Kyle P A, Schiffer C A (Eds) Neoplastic diseases of the blood. Vol 1, 2nd ed. pp 347\u2013372. New York, Edinburgh, London, Melbourne, Tokyo: Churchill Livingstone, 1991."},{"key":"BF4812742_CR2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.V73.4.865.865","volume":"73","author":"B Barlogie","year":"1989","unstructured":"Barlogie B, Epstein J, Selvanayagam P, Alexanian R . Plasma cell myeloma: New biological insights and advances in therapy. Blood 1989; 73: 965\u2013978.","journal-title":"Blood"},{"key":"BF4812742_CR3","unstructured":"Durie B G M . Multiple myeloma. A concise review of the disease and treatment options. UK: International Myeloma Foundation, Nov 2000."},{"key":"BF4812742_CR4","unstructured":"Rose LF, Kaye D . Internal medicine for dentistry. 2nd Ed. pp 366\u2013367. UK: CV Mosby, 1990."},{"key":"BF4812742_CR5","first-page":"557","volume":"36","author":"RG Jagger","year":"1978","unstructured":"Jagger RG, Helkimo M, Carlsson GE . Multiple myeloma involving the temoromandibular joint. J Oral Surg 1978; 36: 557\u2013559.","journal-title":"J Oral Surg"},{"key":"BF4812742_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0190-9622(88)70001-8","volume":"18","author":"SM Breathnach","year":"1988","unstructured":"Breathnach SM . Amyloid and amyloidosis. J Am Acad Dermatol 1988; 18: 1\u201316.","journal-title":"J Am Acad Dermatol"},{"key":"BF4812742_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0190-9622(98)70069-6","volume":"39","author":"DM Touart","year":"1998","unstructured":"Touart DM, Sau P . Cutaneous deposition diseases. Part 1. J Am Acad Dermatol 1998; 39: 149\u2013171.","journal-title":"J Am Acad Dermatol"},{"key":"BF4812742_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/PL00000706","volume":"3","author":"FJ Stevens","year":"2000","unstructured":"Stevens FJ, Kisilevsky R . Immunoglobulin light chains, glycosaminoglycans, and amyloid. Cell Mol Life Sci 2000; 3: 441\u2013449.","journal-title":"Cell Mol Life Sci"},{"key":"BF4812742_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1067\/moe.2002.126342","volume":"94","author":"RIF Van Der Waal","year":"2002","unstructured":"Van Der Waal R I F, Van De Scheur M R, Huijgens P C, Starink T M, Van De Waal I . Amyloidosis of the tongue as a paraneoplastic marker of plasma cell dyscrasia. Oral Surg Oral Med Pathol Oral Radiol Endod 2002; 94: 444\u2013447.","journal-title":"Oral Surg Oral Med Pathol Oral Radiol Endod"},{"key":"BF4812742_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0889-8588(05)70122-2","volume":"13","author":"MA Gretz","year":"1999","unstructured":"Gretz MA, Lacy MQ, Dispenzieri A . Amyloidosis. Haematol Oncol Clin North Am 1999; 13: 1211\u20131233.","journal-title":"Haematol Oncol Clin North Am"},{"key":"BF4812742_CR11","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BGM Durie","year":"1975","unstructured":"Durie BGM, Salmon SE . A clinical staging system for multiple myeloma. Cancer 1975; 36: 842\u2013854.","journal-title":"Cancer"},{"key":"BF4812742_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2141.2003.04456.x","volume":"122","author":"JL Jacobson","year":"2003","unstructured":"Jacobson JL, Hussein MA, Barlogie B, Durie BGM, Crowley JL . A new staging system for multiple myeloma patients based on the southwest oncology group (SWOG) experience. Br J Haematol 2003; 122: 441.","journal-title":"Br J Haematol"},{"key":"BF4812742_CR13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V75.4.823.823","volume":"75","author":"BGM Durie","year":"1990","unstructured":"Durie BGM, Stock-Novack D, Salmon SE et al. Prognostic value of pre treatment serum B2 micro-globulin in myeloma: A South West oncology group study. Blood 1990; 75: 823\u2013830.","journal-title":"Blood"},{"key":"BF4812742_CR14","first-page":"26","volume-title":"Mayo Clinic Proceedings","author":"RA Kyle","year":"1993","unstructured":"Kyle RA . 'Benign' monoclonal gammopathy \u2014 after 20-35 years follow up. Mayo Clinic Proceedings 1993; 68: 26\u201336."},{"key":"BF4812742_CR15","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1001\/jama.1969.03160090040009","volume":"208","author":"R Alexanian","year":"1969","unstructured":"Alexanian R, Haut A, Khan A et al. Treatment for multiple myeloma: combination chemotherapy with different melphalan dose regimes. J Am Med Asso 1969; 208: 1680\u20131685.","journal-title":"J Am Med Asso"},{"key":"BF4812742_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1468-0734.2002.00077.x","volume":"6","author":"JL Harousseau","year":"2002","unstructured":"Harousseau JL . Management of multiple myeloma. Rev Clin Exp Haematol 2002; 6: 253\u2013275.","journal-title":"Rev Clin Exp Haematol"}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/4812742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/4812742","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/4812742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T01:36:49Z","timestamp":1684373809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4812742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["BF4812742"],"URL":"https:\/\/doi.org\/10.1038\/sj.bdj.4812742","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}